Citation Impact
Citing Papers
Angiogenesis Markers Quantification in Breast Cancer and Their Correlation with Clinicopathological Prognostic Variables
2011
Targeting Vascular Pericytes in Hypoxic Tumors Increases Lung Metastasis via Angiopoietin-2
2015
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers
2017
The FGF family: biology, pathophysiology and therapy
2009 Standout
Harmless Herbs? A Review of the Recent Literature
1998 Standout
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review
2020 Standout
Human prostate cancer risk factors
2004
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Hibiscus sabdariffa L. – A phytochemical and pharmacological review
2014 Standout
Epidemiology of Prostate Cancer
2019 Standout
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
2011
Real time MRI-ultrasound image guided stereotactic prostate biopsy
2002
Herbal Medicinals
1998 Standout
The strawberry: Composition, nutritional quality, and impact on human health
2011 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Functional protease profiling for diagnosis of malignant disease
2011
Matrix Metalloproteinases and Other Matrix Proteinases in Relation to Cariology: The Era of ‘Dentin Degradomics'
2015 Standout
Cancer preventive properties of ginger: A brief review
2006 Standout
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Diagnosis of urothelial carcinoma from urine
2009
Bladder cancer
2016 Standout
Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
2010
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
2012
Botanical Drugs, Synergy, and Network Pharmacology: Forth and Back to Intelligent Mixtures
2011
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 Standout
The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer
2014
Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice
2009
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
Phytopharmaceutical and synthetic agents in the treatment of benign prostatic hyperplasia (BPH)
1997
End-to-end design of wearable sensors
2022 Standout
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
1999 Standout
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
2014
Prostatic Specific Antigen
1994
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
Elevated plasma hydroxyproline
1988
A Neutralizing Anti–Fibroblast Growth Factor 8 Monoclonal Antibody Shows Potent Antitumor Activity against Androgen-Dependent Mouse Mammary Tumors In vivo
2005
Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health
2011 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma
2016 StandoutNobel
Inhibitory effect of herbal remedies on 12-o-tetradecanoylphorbol-13-acetate-promoted Epstein–Barr virus early antigen activation
2002
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Conservative management for postprostatectomy urinary incontinence
2015
Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So Far
2013 Standout
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
2015 Standout
Works of Imre Romics being referenced
Angiogenic Switch of Angiopietins-Tie2 System and Its Prognostic Value in Bladder Cancer
2008
Overexpression of CD24, c-myc and Phospholipase 2A in Prostate Cancer Tissue Samples Obtained by Needle Biopsy
2008
A Special Terpene Combination (Rowatinex®) Improves Stone Clearance after Extracorporeal Shockwave Lithotripsy in Urolithiasis Patients: Results of a Placebo-Controlled Randomised Controlled Trial
2010
Matrix metalloproteinase‐7 as a marker of metastasis and predictor of poor survival in bladder cancer
2010
Improving diagnostic accuracy of prostate carcinoma by systematic random map-biopsy
2000
Repeated biopsies in evaluation of therapeutic effects in prostate carcinoma
2001
Serum Levels of Angiogenic Factors and their Prognostic Relevance in Bladder Cancer
2008
High insulin‐like growth factor mRNA‐binding protein 3 (IMP3) protein expression is associated with poor survival in muscle‐invasive bladder cancer
2012
Urinary incontinence and voiding dysfunction after radical retropubic prostatectomy (prospective urodynamic study)
2005
Changes in Prostate-Specific Antigen and Prostatic Acid Phosphatase Concentration following Prostatic Examination in Benign Prostatic Hypertrophy and Prostate Cancer Patients
1992
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy
2010
Detection of bladder cancer from the urine using fluorescencein situ hybridization technique
2007
Study of Serum and Urine Hydroxyproline Level of Patients withProstatic Cancer
1984
Apoptosis, Mitosis, p53, bcl<sub>2</sub>, Ki-67 and Clinical Outcome in Prostate Carcinoma Treated by Androgen Ablation
1999
Experience in treating benign prostatic hypertrophy with Sabal serrulata for one year.
1993
Deletion analysis of tumor and urinary DNA to detect bladder cancer: Urine supernatant versus urine sediment
2007